Loading company…
Moffitt Genetics Corporation, now Aster Insights, runs oncology research platforms, including the Total Cancer Care program.
Established in 2006 and based in Tampa, US, Moffitt Genetics Corporation, Inc., now Aster Insights, runs oncology research platforms, including the Total Cancer Care program, which integrates data from nearly half a million patients, and the ORIEN research exchange network. Clients include pharmaceutical, biotechnology and medical device companies, mainly in North America and Europe. Clayton Dubilier & Rice invested USD 100 mn on March 17, 2021, with McKesson Ventures and Merck Global Health Innovation Fund also involved. It is at the Series C stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in